Topiramate ER 25 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE9JT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,656
Award facts
- Contract value 100% obligated
- $13,656.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 23, 2026, for Topiramate ER 25 mg capsules (30-count units) with a ceiling value of $13,656.45. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for January 26, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order falls within DLA's pharmaceutical procurement operations supporting the Defense Health Agency and broader military medical treatment facilities. Topiramate is an anticonvulsant and neurological medication used in military and veteran healthcare settings. The award demonstrates AmerisourceBergen's continued role as a critical vendor in the federal pharmaceutical supply chain, with the company's ability to compete and win orders through full and open competition on the DLA Medical Supply Chain IDC vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FE9JT?
SPE2DR26FE9JT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FE9JT worth?
The government has obligated $13,656 on SPE2DR26FE9JT.
Is contract SPE2DR26FE9JT an order under another contract?
Yes. SPE2DR26FE9JT is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE9JT competed?
The extent of competition for SPE2DR26FE9JT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award